GlassScriptPhysician profile
Shelby Macrae
NPI 1861924136
$1,523.58
in general payments reported to CMS, 2019-2025
10 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $540 · 2024: $568 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.69 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $693.52 | 2023-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $220.23 | 2023-2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $144.51 | 2022 | |
| Electromed, INC. | $128.62 | 2024-2025 | Smartvest |
| Tactile Systems Technology INC | $89.78 | 2023 | Flexitouch Plus, Entre Plus |
| Genzyme Corporation | $87.62 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $78.53 | 2024-2025 | Nuzyra |
| Baxter Healthcare | $29.57 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $28.91 | 2025 | Vest Therapy Und |
| United Therapeutics Corporation | $22.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Macrae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.